David Salazar
ARTICLES BY THIS AUTHOR
- 1/12/2021
Walgreens Boots Alliance takes majority stake in iA
Walgreens Boots Alliance said its investment in iA was meant to support the company's expansion and help develop automation solutions that would benefit the entire pharmacy industry. - 1/11/2021
Walmart piloting HomeValet smart box home delivery
The retailer’s HomeValet service, currently being tested by consumers in its hometown of Bentonville, Ark., allows Walmart to deliver orders directly to customers’ homes via temperature-controlled, powered smart boxes. - 1/10/2021
Products to Watch: HRG's 5 picks from December 2020
Find out which five products from December stood out to Hamacher Resource Group’s new product team. - 1/6/2021
WBA speeds up investment in VillageMD to accelerate clinic openings
As the companies prepare to build hundreds of Village Medical at Walgreens co-branded clinics, Walgreens Boots Alliance is speeding up its $1 billion investment in VillageMD - 1/6/2021
CRN video series looks to demystify supplement industry
The “4 Things to Know” series features CRN experts offering concise explanations of topics that are central to the supplement industry. - 1/6/2021
Walgreens Boots Alliance’s Q1 results beat expectations
Though WBA swung to a loss for the quarter, solid revenue growth from Walgreens and progress on its strategic priorities buoyed the company in Q1. - 1/5/2021
AmerisourceBergen to buy Alliance Healthcare from WBA
The company is selling Alliance Healthcare to AmerisourceBergen for $6.5 billion in a cash-and-stock transaction comprised of $6.3 billion in cash and 2 million shares of AmerisourceBergen common stock. - 1/3/2021
CRN hires senior communications director
The Council for Responsible Nutrition added Kendall Riley as its senior director of communications in December. - 12/29/2020
Hershey rolls out Valentine’s Day, Easter treats
The company's seasonal innovations include new products from such brands as Reese’s, Ice Breakers and the flagship Hershey’s chocolate brand. - 12/29/2020
FDA clears first generic glucagon for injection kit
Amphastar's generic is a synthetic peptide product that the FDA has deemed to be bioequivalent and thus therapeutically equivalent to Eli Lilly’s Glucagon Emergency Kit for Low Blood Sugar.
